§ 13F · FUND PROFILE
JOHNSON & JOHNSON.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $504M (13F)Positions · 20Turnover · — · Q1Filed · May 13, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$1M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | PTGX | Protagonist Therapeutics Inc. | 2.45M | $258M | 39.6% | ±0% |
| 2 | NBTX | Nanobiotix S.A. | 5.62M | $174M | 26.6% | ±0% |
| 3 | MGTX | MeiraGTx Holdings plc | 6.64M | $58M | 8.8% | ±0% |
| 4 | RAPP | Rapport Therapeutics, Inc. | 1.78M | $56M | 8.6% | ±0% |
| 5 | CVRX | CVRx, Inc. | 4.02M | $38M | 5.8% | ±0% |
| 6 | CTNM | Contineum Therapeutics Inc. | 1.98M | $26M | 4.0% | ±0% |
| 7 | LEGN | Legend Biotech Corporation | 815K | $15M | 2.3% | ±0% |
| 8 | XNCR | Xencor, Inc. | 748K | $9M | 1.4% | ±0% |
| 9 | PRCT | Procept BioRobotics Corporation | 358K | $9M | 1.4% | ±0% |
| 10 | FATE | Fate Therapeutics, Inc. | 3.38M | $4M | 0.6% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE JOHNSON SIGNAL
AC read
JOHNSON & JOHNSON is a Other fund managing $504 million in assets. The fund runs a focused portfolio of just 20 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
4 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed